Head to Head Contrast: Reliq Health Technologies (OTCMKTS:RQHTF) & DarioHealth (NASDAQ:DRIO)

DarioHealth (NASDAQ:DRIO) and Reliq Health Technologies (OTCMKTS:RQHTF) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.

Insider and Institutional Ownership

33.4% of DarioHealth shares are held by institutional investors. Comparatively, 0.0% of Reliq Health Technologies shares are held by institutional investors. 3.5% of DarioHealth shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares DarioHealth and Reliq Health Technologies”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$21.00 million	3.50	-$41.71 million	($6.13)	-1.22
Reliq Health Technologies	N/A	N/A	N/A	N/A	N/A

Reliq Health Technologies has lower revenue, but higher earnings than DarioHealth.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for DarioHealth and Reliq Health Technologies, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1	1	2	0	2.25
Reliq Health Technologies	0	0	0	0	0.00

DarioHealth presently has a consensus price target of $10.00, suggesting a potential upside of 33.51%. Given DarioHealth’s stronger consensus rating and higher possible upside, research analysts clearly believe DarioHealth is more favorable than Reliq Health Technologies.

Profitability

This table compares DarioHealth and Reliq Health Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
DarioHealth	-169.87%	-54.81%	-33.36%
Reliq Health Technologies	N/A	N/A	N/A

Summary

DarioHealth beats Reliq Health Technologies on 6 of the 9 factors compared between the two stocks.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

About Reliq Health Technologies

Reliq Health Technologies Inc., a healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market. It offers iUGO Care platform, a software as a solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc. and changed its name to Reliq Health Technologies Inc. in May 2016. Reliq Health Technologies Inc. was incorporated in 2005 is headquartered in Hamilton, Canada.